Kenji Ichikawa

5.4k total citations
96 papers, 3.6k citations indexed

About

Kenji Ichikawa is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Kenji Ichikawa has authored 96 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 35 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Molecular Biology. Recurrent topics in Kenji Ichikawa's work include Systemic Lupus Erythematosus Research (43 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Platelet Disorders and Treatments (13 papers). Kenji Ichikawa is often cited by papers focused on Systemic Lupus Erythematosus Research (43 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Platelet Disorders and Treatments (13 papers). Kenji Ichikawa collaborates with scholars based in Japan, United Kingdom and United States. Kenji Ichikawa's co-authors include Eiji Matsuura, Takao Koike, Akito Tsutsumi, Tatsuya Atsumi, Takayoshi Koike, Munther A. Khamashta, Takayuki Sumida, Graham R.V. Hughes, G. Balestrieri and Pier Luigi Meroni and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Cell.

In The Last Decade

Kenji Ichikawa

91 papers receiving 3.5k citations

Peers

Countries citing papers authored by Kenji Ichikawa

Since Specialization

Citations

This map shows the geographic impact of Kenji Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ichikawa more than expected).

Fields of papers citing papers by Kenji Ichikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ichikawa. The network helps show where Kenji Ichikawa may publish in the future.

Co-authorship network of co-authors of Kenji Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ichikawa. A scholar is included among the top collaborators of Kenji Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ichikawa. Kenji Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors 2021 ·Bioorganic & Medicinal Chemistry Letters ·Satoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, Norio Murai, Hiroshi Azuma, (unknown), (unknown), (unknown), Kenji Ichikawa, Takayuki Nakagawa, Naoko Hata Sugi, Daisuke Ito, Yu Kato, (unknown), (unknown), Takashi Ueno, Junji Matsui, Tomohiro Matsushima	5
2	Discovery of a potent and selective Axl inhibitor in preclinical model 2021 ·Bioorganic & Medicinal Chemistry ·Satoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, Hiroshi Azuma, (unknown), Norio Murai, (unknown), (unknown), Kenji Ichikawa, Takayuki Nakagawa, Naoko Hata Sugi, Daisuke Ito, Yu Kato, (unknown), (unknown), Takashi Ueno, Junji Matsui, Tomohiro Matsushima	6
3	Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways 2016 ·Kenji Ichikawa, (unknown), Yusuke Adachi, Masahiro Matsuki, Kiyoshi Okamoto, Junji Matsui	6
4	MCRIP1, an ERK Substrate, Mediates ERK-Induced Gene Silencing during Epithelial-Mesenchymal Transition by Regulating the Co-Repressor CtBP 2015 ·Molecular Cell ·Kenji Ichikawa, Yuji Kubota, Takanori Nakamura, (unknown), Taichiro Tomida, Haruo Saito, Mutsuhiro Takekawa	62
5	A Case of Liver Metastasis with Fever Early and Twice Developing after Curative Resection for Transverse Colon Cancer 2007 ·The Japanese Journal of Gastroenterological Surgery ·(unknown), Kenji Ichikawa, (unknown), (unknown)	0
6	Soldering of aluminum alloy 6063 to copper with ultrasonic vibration 2003 ·Journal of Japan Institute of Light Metals ·Takehiko Watanabe, (unknown), Shizuyo KONUMA, Kenji Ichikawa	2
7	Suppressed intrinsic fibrinolytic activity by monoclonal anti‐beta‐2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome 2002 ·British Journal of Haematology ·(unknown), Tatsuya Atsumi, Masahiro Ieko, Yoshiharu Amasaki, Kenji Ichikawa, Takao Koike	35
8	Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren’s syndrome 2001 ·Genes and Immunity ·Akito Tsutsumi, Keisuke Sasaki, Nobutaka Wakamiya, Kenji Ichikawa, Tatsuya Atsumi, Katsuki Ohtani, Yasuhiko Suzuki, Takayoshi Koike, Takayuki Sumida	79
9	β2-glycoprotein I deficiency: 2000 ·Atherosclerosis ·Shinsuke Yasuda, Akito Tsutsumi, Hitoshi Chiba, Hidekatsu Yanai, (unknown), (unknown), Tetsuya Horita, Tatsuya Atsumi, Kenji Ichikawa, Eiji Matsuura, Takao Koike	63
10	A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodies 1999 ·Arthritis & Rheumatism ·Kenji Ichikawa, Akito Tsutsumi, Tatsuya Atsumi, Eiji Matsuura, Seiichi Kobayashi, Graham Hughes, M A Khamashta, Takao Koike	73
11	Evaluation of Layer Thickness to Reduce the Thermal Stress in Multilayer Submerged Entry Nozzles 1998 ·Taikabutsu overseas ·(unknown), (unknown), Kenji Ichikawa, Ryosuke Nakamura, (unknown)	1
12	Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes 1998 ·Arthritis & Rheumatism ·Joan Carles Reverter, Dolors Tàssies, Josep Font, Munther A. Khamashta, Kenji Ichikawa, Ricard Cervera, Ginés Escolar, Graham Hughes, M Ingelmo, A Ordinas	84
13	Arterial disease and thrombosis in the antiphospholipid syndrome: A pathogenic role for endothelin 1 1998 ·Arthritis & Rheumatism ·Tatsuya Atsumi, Munther A. Khamashta, Robert S. Haworth, Gavin Brooks, Olga Amengual, Kenji Ichikawa, (unknown), Graham R.V. Hughes	92
14	Behavior of Metal Additives on Low-Carbon MgO-C Bricks 1997 ·Taikabutsu overseas ·K. Moriwaki, (unknown), Osamu Nomura, Kenji Ichikawa	1
15	Endothelial Cells as a Target for Antiphospholipid Antibodies: Role of Anti‐Beta 2 Glycoprotein I Antibodies 1997 ·American Journal of Reproductive Immunology ·Nicoletta Del Papa, Elena Raschi, Luca Catelli, Pier Luigi Meroni, M A Khamashta, Kenji Ichikawa, (unknown), G. Balestrieri	43
16	Antibodies to β₂‐glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus 1996 ·Arthritis & Rheumatism ·Akito Tsutsumi, Eiji Matsuura, Kenji Ichikawa, Atsushi Fujisaku, Masaya Mukai, Seiichi Kobayashi, Takao Koike	163
17	Effects of Mg-B Material Addition to Al_2O_3-C SV Plate 1995 ·Taikabutsu overseas ·Kenji Ichikawa, (unknown), Osamu Nomura, (unknown)	2
18	Application of Spinel Checker Brick for Glass Furnace Regenerators 1995 ·Taikabutsu overseas ·Kenji Ichikawa, (unknown), (unknown), Masanori Ogata	3
19	Suppression Effects of Aluminum on Oxidation of MgO-C Bricks 1995 ·Taikabutsu overseas ·Kenji Ichikawa, (unknown), Osamu Nomura, (unknown)	11
20	Glucose semipermeable membrane in the glucose sensor for the artificial pancreas. 1987 ·NIPPON KAGAKU KAISHI ·Shoichiro Ikeda, (unknown), Kaname Ito, Kenji Ichikawa, (unknown), (unknown), Akimasa Nakao, H Ichihashi, Tatsuhei Kondo, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact